Compass Therapeutics (CMPX) Enterprise Value Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.98% |
| Dec 31, 2025 | -64.56% |
| Sep 30, 2025 | -86.34% |
| Jun 30, 2025 | 30.58% |
| Mar 31, 2025 | 35.70% |
| Dec 31, 2024 | 16.51% |
| Sep 30, 2024 | 27.92% |
| Jun 30, 2024 | 13.35% |
| Mar 31, 2024 | -0.51% |
| Dec 31, 2023 | 18.28% |
| Sep 30, 2023 | -35.74% |
| Jun 30, 2023 | -27.82% |
| Mar 31, 2023 | -28.42% |
| Dec 31, 2022 | -29.10% |
| Sep 30, 2022 | -372.95% |
| Mar 31, 2022 | -243.62% |
| Dec 31, 2021 | -206.98% |
| Sep 30, 2021 | 54.07% |
| Mar 31, 2021 | -1,059,846.60% |
| Dec 31, 2020 | -86.05% |
| Sep 30, 2020 | -6,294,457.82% |
| Jun 30, 2020 | -1,343,323.76% |
| Mar 31, 2020 | 23.04% |
| Dec 31, 2019 | -540,677.94% |
| Sep 30, 2019 | 63.94% |
| Jun 30, 2019 | 32.71% |